Science Explorer Interactive view Map
Company · Seoul · South Korea

Novartis (South Korea)

novartis.co.krROR OpenAlex
Research works
21
▲ 21% vs 2013–17
Citations
155
7.2 per fractional work
Top-10% rate
3.6%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Novartis (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.79× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.48× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 28.19× its world share, 0 worksPharmacology, Toxico…Medicine: 3.98× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 3.48× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 28.2×. Every wedge is a field page.

Which keywords describe research at Novartis (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Treatment, Diagnosis, Heart Failure, Cardiovascular Disease, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Epidemiology4▲ 4.1×12 topics
  2. Quality of Life3▲ 9.0×5 topics
  3. Treatment2▲ 8.3×5 topics
  4. Diagnosis2▲ 8.9×5 topics
  5. Cardiovascular Disease2▲ 7.1×4 topics
  6. Cost-effectiveness Analysis2▲ 96×1 topic
  7. Health Utility Measures2▲ 96×1 topic
  8. Heart Failure2▲ 17×5 topics
  9. Inflammation2▲ 3.1×5 topics
  10. Pharmaceutical Industry1▲ 160×2 topics
  11. Asthma1▲ 43×2 topics
  12. Diagnostic Criteria1▲ 26×2 topics
  13. B-Type Natriuretic Peptide1▲ 115×1 topic
  14. Guidelines1▲ 11×1 topic
  15. Multiple Sclerosis1▲ 139×1 topic
  16. Neuromyelitis Optica1▲ 139×1 topic

Which research topics does Novartis (South Korea) publish most on?

By volume in 2022–2025: Spondyloarthritis Studies and Treatments, Advanced Breast Cancer Therapies, Infectious Diseases and Tuberculosis and Economic and Financial Impacts of Cancer.

Spondyloarthritis Studies and Treatments: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksInfectious Diseases and …0Infectious Diseases and Tuberculosis: 0 fractional worksEconomic and Financial I…0Economic and Financial Impacts of Cancer: 0 fractional worksIgG4-Related and Inflamm…0IgG4-Related and Inflammatory Diseases: 0 fractional worksRetinal Diseases and Treatments: 0 fractional worksCutaneous lymphoproliferative disorders research: 0 fractional worksPharmacovigilance and Adverse Drug Reactions: 0 fractional worksDrug-Induced Hepatotoxicity and Protection: 0 fractional worksPoisoning and overdose treatments: 0 fractional works
RheumatologyPulmonary and Respiratory MedicineSurgeryEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  3. 3 Infectious Diseases and Tuberculosis Surgery 0 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  5. 5 IgG4-Related and Inflammatory Diseases Rheumatology 0 works
  6. 6 Retinal Diseases and Treatments Ophthalmology 0 works
  7. 7 Cutaneous lymphoproliferative disorders research Dermatology 0 works
  8. 8 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  9. 9 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works
  10. 10 Poisoning and overdose treatments Emergency Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 28% of research is openly available.

with international co-authors19.1%domestic only80.9%

World: 19% is written across borders.

How has Novartis (South Korea)'s research output changed?

Output in 2018–2022 was 21% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.